Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $135.95 USD
Change Today +0.24 / 0.18%
Volume 9.3K
As of 10:26 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

chemed corp (CHE) Snapshot

Open
$134.27
Previous Close
$135.71
Day High
$135.95
Day Low
$134.16
52 Week High
08/10/15 - $153.98
52 Week Low
10/16/14 - $97.85
Market Cap
2.3B
Average Volume 10 Days
190.7K
EPS TTM
$6.20
Shares Outstanding
16.9M
EX-Date
08/13/15
P/E TM
21.9x
Dividend
$0.96
Dividend Yield
0.66%
Current Stock Chart for CHEMED CORP (CHE)

chemed corp (CHE) Related Businessweek News

View More BusinessWeek News

chemed corp (CHE) Details

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing and drain cleaning services to residential and commercial customers. The company was founded in 1970 and is based in Cincinnati, Ohio.

14,190 Employees
Last Reported Date: 02/27/15
Founded in 1970

chemed corp (CHE) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $904.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $485.8K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $627.2K
Executive Vice President
Total Annual Compensation: $329.5K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $262.5K
Compensation as of Fiscal Year 2014.

chemed corp (CHE) Key Developments

Chemed Announces Quarterly Dividend, Payable on Sept. 4, 2015

Chemed will pay a quarterly dividend of $0.24 a share, an increase of 9.1% from the prior quarter. The dividend will be paid on Sept. 4, 2015 to investors on record as of Aug. 17, 2015.

Chemed Corp. Announces Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

Chemed Corp. announced consolidated unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported service revenues and sales of $381,921,000 against $360,182,000 a year ago. Income from operations was $44,600,000 against $41,519,000 a year ago. Income before income taxes was $44,167,000 against $39,846,000 a year ago. Net income was $26,975,000 against $24,363,000 a year ago. Diluted earnings per share were $1.55 against $1.36 a year ago. EBITDA was $53,800,000 against $50,282,000 a year ago. Adjusted EBITDA was $57,689,000 against $52,213,000 a year ago. Adjusted net income was $29,716,000 against $26,580,000 a year ago. Adjusted diluted earnings per share were $1.71 against $1.50 a year ago. The revenue growth translated into a 10.7% increase in net income. Excluding special items, Chemed's net income increased 11.8%. For the full year, the company reported service revenues and sales of $758,573,000 against $718,482,000 a year ago. Income from operations was $85,171,000 against $78,171,000 a year ago. Income before income taxes was $84,332,000 against $73,499,000 a year ago. Net income was $51,512,000 against $44,937,000 a year ago. Diluted earnings per share were $3.05 against $2.59 a year ago. Net cash provided by operating activities was $69,638,000 against $45,113,000 a year ago. Capital expenditures were $18,846,000 against $19,454,000 a year ago. EBITDA was $103,542,000 against $95,908,000 a year ago. Adjusted EBITDA was $110,538,000 against of $99,885,000 a year ago. Adjusted net income was $56,547,000 against $50,293,000 a year ago. Adjusted diluted earnings per share were $3.25 against $2.81 a year ago. The company management estimates that full-year 2015 adjusted earnings per diluted share, which excludes non-cash expense for stock options, costs related to litigation, and other discrete items, will be in the range of $6.60 to $6.75. This compares to Chemed’s 2014 reported adjusted earnings per diluted share of $6.07.

Chemed Corp. to Report Q2, 2015 Results on Jul 23, 2015

Chemed Corp. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Jul 23, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHE:US $135.95 USD +0.24

CHE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amedisys Inc $39.93 USD -0.50
Integra LifeSciences Holdings Corp $62.41 USD +0.02
Masimo Corp $39.76 USD -0.305
STERIS Corp $64.13 USD -0.105
West Pharmaceutical Services Inc $55.45 USD +0.11
View Industry Companies
 

Industry Analysis

CHE

Industry Average

Valuation CHE Industry Range
Price/Earnings 22.6x
Price/Sales 1.5x
Price/Book 4.8x
Price/Cash Flow 16.5x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMED CORP, please visit www.chemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.